Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations.

Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. Abstract Text:

D Zhu,M L Kennerson,G Walizada,S ,J M Vance,G A Nicholson,

Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. Publishing Authors By Initials

D Zhu,ML Kennerson,G Walizada,S ,JM Vance,GA Nicholson,

For similar genetic phenomena: variation (genetics) research abstracts see: genetic phenomena: variation (genetics) research

PUBMED ID PMID:

MEDLINE DATE:

Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Neurology

VOLUME: 65

Page Numbers: 496-7

Journal Abbreviation: Neurology

ISSN: 1526-632X

DAY: 9

MONTH: Aug

YEAR: 2005

Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 401060

Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. Keywords Mesh Terms:

KEYWORDS: Variation (Genetics)

MESH TERMS: genetics

Chemical & Substance for Abstract: Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. Information

Substance Name: Kinesin

Registry Number: EC 3.6.1.-

Grant and Affiliation Information for Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations.

AFFILIATION: ANZAC Research Institute, University of Sydney, Concord Hospital, NSW, Australia. danqing@med.usyd.edu.au

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neurology

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations Related Publications

• Baring the soul: Paul Bindrim, Abraham Maslow and 'nude psychotherapy'.
• Changes in adolescents' sources of cigarettes.
• Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations.
• Detection of urinary drug metabolite (xenometabolome) signatures in molecular epidemiology studies via statistical total correlation (NMR) spectroscopy.
• Helping parents with mental illness.
• Identification of QTLs for resistance to Fusarium head blight, DON accumulation and associated traits in the winter wheat variety Arina.
• Influenza vaccination and asthma: current studies and recommendations.
• Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts.
• Metabolism of 2-fluoro-4-iodoaniline in earthworm Eisenia veneta using (19)F-NMR spectroscopy, HPLC-MS, and HPLC-ICPMS ((127)I).
• Methadone for cancer pain.
• Microarray-based approach for genome-wide survey of nucleotide polymorphisms.
• Misidentification of Bordetella bronchiseptica as Bordetella pertussis using a newly described real-time PCR targeting the pertactin gene.
• Multiple roles of M-CSF in human osteoclastogenesis.
• One year on, the message from Nicholson is that he's listening.
• Polymorphisms of the prion gene promoter region that influence classical bovine spongiform encephalopathy susceptibility are not applicable to other transmissible spongiform encephalopathies in cattle.
• Potential role of the antioxidant N-acetylcysteine in slowing bone resorption in early post-menopausal women: a pilot study.
• Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: the consortium on metabonomic toxicology screening approach.
• Prolyl cis-trans isomerization as a molecular timer.
• Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer.
• Proton magnetic resonance spectroscopy of human urine: Excretion of 1-(3'-carboxypropyl)-3,7-dimethylxanthine by man after dosing with oxpentifylline.
• Shear bond strengths of glass-ionomer cements to sound and to prepared carious dentine.
• Solid phase extraction chromatography and NMR spectroscopy (SPEC-NMR) for the rapid identification of drug metabolites in urine.
• The autonomous premature unit.
• The child friendly healthcare initiative--an update.
• The effects of oestrogen receptors alpha and beta on testicular cell number and steroidogenesis in mice.
• The omega-atracotoxins: selective blockers of insect M-LVA and HVA calcium channels.
• The roles of mutation accumulation and selection in loss of sporulation in experimental populations of Bacillus subtilis.
• Thermodynamic dissection of the Ezrin FERM/CERMAD interface.
• Topographical variation in metabolic signatures of human gastrointestinal biopsies revealed by high-resolution magic-angle spinning 1H NMR spectroscopy.
• Weight gain may contribute to increased fracture risk in women treated with rosiglitazone.